IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5+ B‐ and T‐cell trafficking to tumor‐conditioned media

Overview of attention for article published in Immunology & Cell Biology, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 12,243 followers.

ICB Original Article: IRF5 a novel regulator of CXCL13 in breast cancer http://t.co/9jDfFLHIZz #Immunology #ASImmuno http://t.co/U99SR0Chkr

IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5+ B- and T-cell… http://t.co/fGyq2PgkwA #immcellbioTCB

Pubmed: IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell… http://t.co/D4xAyBRVzQ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.